FDA Authorizes Novavax’s Updated Covid Vaccine for Fall Rollout
The U.S. Food and Drug Administration (FDA) has authorized Novavax’s updated protein-based Covid vaccine for emergency use in individuals aged 12 and older. This move clears...
The U.S. Food and Drug Administration (FDA) has authorized Novavax’s updated protein-based Covid vaccine for emergency use in individuals aged 12 and older. This move clears...
Moderna experienced a significant 20% drop in its stock price on Thursday after reporting second-quarter results that, while beating revenue expectations, prompted the company to sharply...